Drug Profile
CDP-ethanolamine
Latest Information Update: 01 Oct 2004
Price :
$50
*
At a glance
- Originator Neurovation
- Class Ethanolamines; Nootropics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Alzheimer's disease; Cognition disorders; Craniocerebral trauma; Epilepsy; Stroke
Most Recent Events
- 26 Aug 2002 Discontinued - Preclinical for Alzheimer's disease in USA (unspecified route)
- 26 Aug 2002 Discontinued - Preclinical for Cognition disorders in USA (unspecified route)
- 26 Aug 2002 Discontinued - Preclinical for Epilepsy in USA (unspecified route)